SUMMARY In a previous study employing conventional immunological marker analysis we found that 17% of high grade malignant lymphomas were devoid of cytoplasmic and membrane immunoglobulin and also sheep erythrocyte receptors. Cryostat sections from 24 of these cases (four of low grade and 20 of high grade malignancy) were stained with a panel of 30 monoclonal antibodies and six polyclonal antisera using a sensitive immunoperoxidase method. All tumours expressed the leucocyte common antigen (detected by monoclonal antibody 2D1) and all lacked epithelial cytokeratin (monoclonal antibody LE61), confirming their haematopoietic origin. All but one of the lymphomas expressed antigens characteristic of either B cells ( 17 cases) or T cells (six cases), while one case (morphologically a centroblastic lymphoma) had an unusual dual phenotype in which strong staining for T6 (marker of immature T cells) was associated with expression of the pan B lymphocyte antigens detectable with Tol5, anti-B1, anti-Leul2. This case was therefore classified as a B cell lymphoma showing aberrent expression of the T6 antigen. The pan B cell antibodie's (Tol5, anti-Bi, anti-Leul2) all appeared highly specific and sensitive, but the simultaneous use of all three monoclonal antibodies was necessary to detect the B cell nature in each of the 18 lymphomas. A wider panel of monoclonal antibodies was required to detect T lymphomas since these often disclosed atypical and restricted phenotypes. Tol5 and UCHT1 were the most reliable antibodies for the detection of B and T cell neoplasms, respectively. We conclude that most, if not all, "non-B, non-T" lymphomas are of either B or T lymphocyte origin and that monoclonal antibodies provide indispensable tools in their classification and diagnosis.
Non-Hodgkin's lymphomas which lack conventional B and T cell markers (cytoplasmic and surface membrane immunoglobulin and sheep erythrocyte receptors) constitute a major taxonomic challenge. In a previous study of marker expression in high grade lymphomas we found that 17% were "null" cases. ' In several other series, however, the figure has exceeded 50%. [2] [3] [4] Since the real nature of such null lymphomas remains obscure, the advent of monoclonal anti- 
ML,hg. The B cell antigens with a restricted distribution detected with the monoclonal antibodies Tul and 38 13 were of no particular value in this study since they were present on only a few B cell neoplasms ( Table 2) .
T cell lymphomas Whereas most of the 18 B cell lymphomas were stained by all or most of the pan-B cell antibodies, the 6 T cell lymphomas showed variable reactions 915 with the T cell antibodies. The pan-T lymphocyte antibodies OKT3, UCHT1, anti-Lyt2, Tu71, and Tu33 stained only 3, 4, 2, 2, and 3 of the 6 T lymphomas, respectively ( Table 2 ). The two antibodies against the 67 000 MW T cell marker (anti-Lyt2 and Tu71) showed the same staining pattern, but the two antibodies against the 19-29 000 MW T cell marker (OKT3 and UCHT1) differed clearly in the reactions, as seen in case 13, which showed strong expression of UCHT1 but was T3 negative.
In general, the sheep erythrocyte receptor negative T lymphomas showed aberrent phenotypes. One case (case 18), a cutaneous lymphoblastic lymphoma, unclassified, expressed only the T helper cell associated antigens T4 and Leu3a, and was devoid of other T cell antigens. The case of Lennert' s lymphoma (case 4), supposed to represent a proliferation of peripheral T lymphocytes, expressed the T3 antigen and lacked the T6 antigen, but was devoid of both T helper and T suppressor cell associated antigens.
It is of interest that none of the four T lymphoblastic lymphomas expressed the T6 antigen, a marker commonly present on immature T cell neoplasms. In line with our previous observations, however, the two cases of lymphoblastic lymphoma of Tu35 anti-Ia LeulO Leu7 Phenotype The results of our study indicated that all of these non-B, non-T lymphomas expressed antigens associated with either the B or the T cell lineage; only one lymphoma (case 11) was exceptional in that it expressed both B and T cell markers. Since the only T cell antigen expressed was T6, however, and since the B cell antigens detectable with Tol5, anti-Bl, and anti-Leul2 were all expressed in this case (the morphology of which was typical of a diffuse centroblastic lymphoma), we considered this neoplasm a true B lymphoma. In this context it may be noted that OKT6 is known to react with several types of non-T cells-that is, Langerhans' cells, 917 interdigitating reticulum cells, and even neuroblastoma cells.28
The three pan-B cell antibodies Tol5, anti-Bi, and anti-Leul2 all appeared highly specific and reliable in detecting B cell lymphomas, but the simultaneous use of each of these monoclonal antibodies was necessary to detect the B cell nature of each of the 18 lymphomas.
A wider panel of T cell associated antibodies proved necessary to detect the six lymphomas ultimately phenotyped as T derived since each of the pan-T cell antibodies used (OKT3, UCHT1, antiLyt2, 1Tu71, and Tu33) reacted with only some of these neoplasms.
ToI5 and UCHT1 were the single most reliable antibodies for detecting B and T cell neoplasms, respectively.
An additional feature of the T cell lymphomas in the present study deserves comment. At present, no commonly recognised immunological marker analogous to the immunoglobulin light chain restriction of B lymphomas allows the monoclonality of T cell proliferations to be shown. However, the uniform expression of aberrent phenotypes by cells of such T cell proliferations constitutes an indirect way of identifying their neoplastic nature.
In conclusion, all non-B, non-T lymphomas of our study could be referred to either the B or the T lymphocyte lineage after immunohistochemical investigation with an extensive panel of monoclonal antibodies. This suggests that true non-B, non-T lymphomas are rare, if not non-existent. This investigation also shows the potency of monoclonal antibodies as tools for taxonomic and diagnostic lymphoma work.
